When an unexpected respiratory illness strikes near a high-security pathogen facility, global alarm bells tend to ring – especially when that lab handles dangerous historical diseases. That exact scenario unfolded in early October 2026 in Siberia’s Irkutsk region after Darya Shipilova, a researcher at the regional Anti-Plague Research Institute, died suddenly from severe pneumonia, as reported by Reuters. Because her institute specifically studies Yersinia pestis, the bacterium responsible for the plague, health authorities moved quickly out of an abundance of caution. Russian officials quarantined roughly 200 close contacts, sealed off hospital wards in the nearby town of Shelekhov, and launched an emergency inquiry to determine if her death was caused by an occupational leak or an ordinary community bug.
Fortunately, extensive contact tracing quickly put the worst fears to rest. Health officials found no evidence of plague transmission, instead discovering that the isolated cases among the quarantined individuals were simply common respiratory infections such as COVID-19 and rhinovirus. While this particular incident turned out to be a false alarm, it highlighted why biosafety protocols are so aggressive around high-containment facilities. The sheer virulence of Yersinia pestis, the distinct forms plague can take and the necessity of rapid antibiotic intervention explain why even a single unexplained lab illness triggers an immediate, large-scale containment response.
Can you still get the plague in 2026?
According to the World Health Organization (WHO), plague can infect humans in 2026, as the bacterium that causes the disease is still naturally present in animal reservoir hosts across several continents.
A CNN publication notes that 1,000 to 2,000 cases of human plague are reported to international authorities annually. It is naturally endemic in various parts of Africa, including the Democratic Republic of the Congo and Madagascar, where it is often the main source of cases worldwide. Peru, Central Asia and parts of the western United States are also impacted.
Although infection in people is uncommon in modern urban areas, thanks to modern sanitation and vector control, natural wildlife reservoirs maintain the bacteria in rural and wilderness areas.
What is the plague?
As explained by the U.S. Centers for Disease Control and Prevention (CDC), plague is a severe, acute zoonotic disease caused by Yersinia pestis, a Gram-negative, rod-shaped, facultatively anaerobic bacterium.
Plague has historically caused pandemics, such as the Justinian Plague (6th century) and the Black Death (14th century), which killed an estimated third of the European population, and is classified as a Tier 1 select biological agent, a National Institutes of Health (NIH) publication explains.
In wildlife ecology, the bacterium circulates primarily among small wild rodents such as marmots, ground squirrels, voles and prairie dogs, from one host to another via rodent fleas. Siberia is an ancient geographic cradle of the disease, with endemic foci in wild rodent populations across the vast taiga and steppe regions.
Plague presents in three main clinical forms, depending on the type of exposure. The most common type is bubonic plague, which results from an infected flea biting a person and leads to painful, swollen lymph nodes known as “buboes.” Septicemic plague is the direct multiplication of bacteria in the blood, which causes tissue necrosis and gangrene. Pneumonic plague, the most deadly and virulent form, occurs when the bacteria enter the pulmonary tissue and cause an acute pneumonia, which can be spread directly from one human to another through infectious respiratory droplets.
What’s happening in your body
Invading the human body, Yersinia pestis has an arsenal of sophisticated molecules that turn off the host’s immune system before rapid cellular destruction sets in.
The bacterium has a specialized Type III secretion system, or “molecular syringe” (T3SS), as reported in biochemical research published by the National Institutes of Health (NIH). When the bacterium comes into contact with host immune cells, such as macrophages and neutrophils, it injects outer proteins, called Yops (Yersinia outer proteins), directly into the host cell cytoplasm. These proteins are effectors that disrupt the cell’s internal cytoskeleton, inhibit phagocytosis, and block the release of pro-inflammatory cytokines, allowing the pathogen to survive and multiply in lymphoid tissues without the host noticing.
In pneumonic plague, bacteria quickly inhabit the air sacs of the lungs. In the first 24-36 hours, patients enter an “anti-inflammatory” phase, during which bacterial growth is unrestricted, although this does not result in pulmonary signs or symptoms. When the bacteria reach a critical mass, they enter a hyperinflammatory stage, an uncontrolled phase of the infection.
Neutrophils migrate to the lungs in large numbers, causing severe tissue damage, alveolar capillary leakage and diffuse intra-alveolar hemorrhage. This acute respiratory failure results in severe cyanosis, pulmonary edema, bilateral consolidations and septic shock with rapid onset of death, unless therapeutic interventions are performed within hours of the clinical onset.
Causes of plague symptoms
The symptoms of plague result from active bacterial invasion and the resulting microvascular damage from endotoxins and immune collapse.
The bubonic symptoms develop when bacteria travel from the flea bite to the regional lymph nodes in the armpit, groin or neck, resulting in the formation of egg-sized, tender, and inflamed buboes, which are accompanied by sudden high fevers, chills and muscle aches, notes the Cleveland Clinic.
Septicemic spread is rapid entry into the systemic circulation, resulting in disseminated intravascular coagulation (DIC) and microthrombi that impede circulation to distal parts of the body, leading to localized gangrene distal to the joints and blackening of the fingers, toes and lips.
The pneumonic symptoms are either secondary to disseminated disease in the bloodstream or primary, resulting from inhalation of microscopic droplets from a coughing human or animal host. The clinical signs of primary pneumonic plague include sudden-onset high fever, chest pain, rapid breathing, shortness of breath and a productive cough with watery, bloody sputum.
Is there a plague vaccine?
Tunde Rasheed, B.Sc. A researcher in Chemical and Polymer Medical Engineering explains to Blavity Health, “At this time, no plague vaccine is widely available and universally licensed for use in the general population of the USA or Western Europe. Legacy whole-cell killed plague vaccines were previously used for high-risk military service members and some laboratory workers, but were discontinued due to their lack of effectiveness in protecting against primary pneumonic plague and the high incidence of booster reactions with attendant local reactogenicity.”
Next-generation recombinant subunit vaccines are the focus of active biomedical research funded by the NIH and defense research agencies worldwide. The experimental formulations target two important protective antigens on the bacterial surface: the capsular F1 antigen and the V virulence antigen.
Several candidate vaccines have proven effective against aerosol challenge with pneumonic disease in animal models used in clinical trials. Still, none have been broadly submitted for regulatory approval, and rapid deployment of antibiotics remains the front line of defense against outbreaks.
Health risks and complications
Plague is one of the most life-threatening infectious diseases in history, with high mortality rates and a sharp curve of mortality.
Without timely antimicrobial treatment, untreated bubonic plague has a case-fatality rate of 30-60%, and primary pneumonic plague is almost always fatal (nearly 100% mortality), according to clinical parameters monitored by the WHO.
For pneumonic patients, the window of opportunity for effective medical treatment is extremely limited; patients often decompensate into fatal refractory shock and acute respiratory distress syndrome within 18 to 24 hours of the onset of respiratory symptoms.
Other systemic complications include irreversible multiorgan failure, diffuse peripheral gangrene (leading to amputation of limbs), seeding of the central nervous system by organisms causing bacterial meningitis, and consumption of the body’s own clotting factors by disseminated intravascular coagulation.
What to do about plague symptoms and exposure
If a person has been exposed to plague, it is a serious medical emergency; they should be hospitalized, isolated from others, evaluated for respiratory symptoms, and treated with appropriate antimicrobials ASAP.
CDC guidelines for first-line antibiotic treatment include intravenous aminoglycosides (gentamicin or streptomycin), fluoroquinolones (ciprofloxacin or levofloxacin), and tetracyclines (doxycycline). Antibiotic treatment to achieve survival should be started within 24 hours of symptom onset, even before confirmatory laboratory cultures are available.
Health authorities take stringent post-exposure prophylaxis (PEP) measures for people who have been in close contact with a suspected or confirmed pneumonic plague patient, including sharing of enclosed spaces. To stop secondary spread of disease in the community, contacts are provided with a 7-day course of oral doxycycline or ciprofloxacin and daily temperature monitoring.
Never handle sick or dead wild rodents, rabbits, or prairie dogs when camping, hiking, or working outdoors in plague-endemic areas (such as the Southwest USA or rural Central Asia). Apply EPA-approved insect repellents (ones with DEET) to your skin and treat pets with a veterinarian-recommended flea control product; pet dogs and outdoor cats can carry infected rodent fleas right into the house.
When to see a doctor
Anyone who has been in plague-endemic wilderness areas or exposed to infected animals or laboratory situations and who develops a sudden onset of high fever, chills, enlarged lymph nodes, or rapid breathing should seek immediate emergency medical attention.
The Mayo Clinic lists some emergency signs that are red flags:
- Coughing up bloody, frothy or pink sputum with a severe sense of chest tightness.
- A sudden onset of painfully swollen, hot and tender lymph nodes in the groin, armpit, or neck.
- Rapid onset of dizziness, cold and clammy hands and feet, confusion, or blue/purple fingers and toes.
The diagnosis is confirmed by clinicians through the collection of blood, sputum, and lymph node aspirates for specialized Gram staining, rapid antigen detection assays, and polymerase chain reaction (PCR) assays at designated public health reference laboratories.
“Plague is still endemic in many parts of the world, including western parts of the U.S., [but] there shouldn’t be too much concern as the transmission of Yersinia pestis between humans is generally poor,” Brendan Wren, professor at the London School of Hygiene & Tropical Medicine, says.
Bottom line
The preventive quarantines in Siberia after the death of one of the workers in a plague research laboratory are a reminder of how crucial biosafety and timely public health contact tracing can be. Plague, caused by the bacterium Yersinia pestis, occurs in bubonic, septicemic and highly fatal pneumonic forms and remains present in wild rodent populations worldwide. Untreated pneumonic infections can result in rapid deterioration and death from respiratory failure within 24 hours. Still, if the infection is identified early, prophylactically isolated and treated with standard antibiotics such as gentamicin and doxycycline, it is readily cured, and secondary spread to the community is prevented.
Frequently Asked Questions
Is a pandemic the same as a plague?
No, a plague is a specific bacterial infection caused exclusively by Yersinia pestis. In contrast, a pandemic is a broad epidemiological term describing any infectious disease that spreads across multiple countries or continents simultaneously.
Was COVID-19 worse than the plague?
In terms of historical lethality, the Black Death plague was significantly more devastating, killing an estimated 30% to 60% of the entire European population with untreated mortality rates approaching 100% for pneumonic forms, whereas COVID-19 had a far lower individual fatality rate but caused massive worldwide societal and economic disruption.
Citations
Osborn A. Dozens quarantined in Siberia after plague institute lab worker dies. Reuters. October 5, 2026. https://www.reuters.com/business/healthcare-pharmaceuticals/dozens-quarantined-siberia-after-plague-institute-lab-worker-dies-2026-10-05/
World Health Organization. Plague. World Health Organization. July 7, 2022. https://www.who.int/news-room/fact-sheets/detail/plague
Andrew S. Every year, between 1,000 to 2,000 people get the plague – including about 7 in the US. CNN. November 14, 2019. https://edition.cnn.com/2019/11/14/health/plague-likelihood-around-the-world-trnd
CDC. About Plague. CDC. April 18, 2024. https://www.cdc.gov/plague/about/index.html
Bennasar-Figueras A. The Natural and Clinical History of Plague: From the Ancient Pandemics to Modern Insights. Microorganisms. 2024;12(1):146. doi:10.3390/microorganisms12010146
Cleveland Clinic. Plague: What Is It, How Do You Get It & Symptoms. Cleveland Clinic. August 22, 2022. https://my.clevelandclinic.org/health/diseases/17782-plague
Eslami M, Bahram Fadaee Dowlat, Shayan Yaghmayee, et al. Next-Generation Vaccine Platforms: Integrating Synthetic Biology, Nanotechnology, and Systems Immunology for Improved Immunogenicity. Vaccines. 2025;13(6):588-588. doi:10.3390/vaccines13060588
CDC. Guidance for Responding to a Plague Bioterrorism Event. Plague. September 21, 2026. https://www.cdc.gov/plague/hcp/emergency-guidance/index.html
Mayo Clinic. Plague – Symptoms and causes. Mayo Clinic. April 20, 2023. https://www.mayoclinic.org/diseases-conditions/plague/symptoms-causes/syc-20351291
